imidazole has been researched along with Myocardial Ischemia in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JF | 1 |
| Chen, M | 1 |
| Liu, B | 1 |
| Hou, Z | 1 |
| Arrhenius, T | 1 |
| Nadzan, AM | 1 |
1 other study available for imidazole and Myocardial Ischemia
| Article | Year |
|---|---|
Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
Topics: Animals; Carboxy-Lyases; Cardiotonic Agents; Drug Design; Energy Metabolism; Enzyme Inhibitors; Fatt | 2006 |